Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorUniversity of Sao Paulo

About this trial

Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.

Eligibility criteria

Qualifiers

History of one or more previous episodes of traumatic glenohumeral dislocation;

Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;

Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of bone lesion of the glenoid;

Instability Severity Index Score of (ISIS) greater than or equal to 4 points, with anterior glenoid bone loss (bone Bankart lesion) greater than 13.5% of their diameter, measured by the method described by Sugaya et al.;

Disqualifiers

Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);

Untreated seizures;

Previously diagnosed rotator cuff complete tear;

Fractures of the proximal humerus (except for Hill-Sachs lesions);

Trial design

Treatments tested in this trial

  • Latarjet procedure
  • Modified Eden-Hybinette

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Sao Paulo

Lead sponsor

Faculdade de Medicina de Jundiaí

Collaborator